Associations between hypovitaminosis D and COVID-19: a narrative review

Aging Clin Exp Res. 2020 Sep;32(9):1879-1881. doi: 10.1007/s40520-020-01650-9. Epub 2020 Jul 23.

Abstract

In the search for factors affecting incidence and lethality of the current COVID-19 pandemic, recent association studies explored the possible role of vitamin D deficiency. Altogether, these studies, in most cases based on cross-sectional analyses, could not yet provide a convincing demonstration of a cause-effect relationship. In this editorial, the authors describe the scientific evidence underlying a possible role of vitamin D in the prevention and development of the pandemic, considering its immunomodulatory role and antiviral effects. They conclude that further studies are needed to (1) better explore possible associations between vitamin D deficiency and COVID-19 morbidity and lethality, and (2) assess if compensating such deficiency could avoid or mitigate the worst manifestations of COVID-19. They highlight the need for public health campaigns to promote consumption of vitamin D-rich foods and proper sunlight exposition or, when this is not possible, controlled pharmaceutical supplementation, especially in countries with high prevalence of hypovitaminosis D.

Keywords: COVID-19; Immune system; Viral infections; Vitamin D deficiency.

Publication types

  • Review

MeSH terms

  • COVID-19* / immunology
  • COVID-19* / metabolism
  • COVID-19* / prevention & control
  • Dietary Supplements
  • Humans
  • Immunologic Factors / immunology
  • Immunologic Factors / pharmacology
  • Pandemics* / prevention & control
  • Prevalence
  • SARS-CoV-2
  • Vitamin D Deficiency* / epidemiology
  • Vitamin D Deficiency* / immunology
  • Vitamin D Deficiency* / therapy
  • Vitamin D* / administration & dosage
  • Vitamin D* / immunology

Substances

  • Immunologic Factors
  • Vitamin D